Miral Medical Clinics Company announces to its shareholders the results of the extraordinary general assembly meeting (first meeting), which was held at 19:30 pm on Wednesday, 02/10/1446 AH, corresponding to 08/14/2024 AD, at the company’s main headquarters located in the city of Riyadh - Olaya District - Prince Muhammad bin Abdulaziz Road, through modern technology means (remotely) - using Tadawulati services; This is after the legal quorum is reached for the assembly to be held, and the meeting was at the company’s main headquarters in Riyadh - Olaya District - Prince Muhammad bin Abdulaziz Road - via modern technology (remotely) - using Tadawulati services, Percentage of Attending Shareholders 75.90%. The voting results were as follows: 1. Approval of the company’s auditor’s report for the financial year ending on December 31, 2023, AD after discussing it. 2. The Board of Directors’ report for the financial year ending on December 31, 2023, was reviewed and discussed. 3. The company’s financial statements for the fiscal year ending on December 31, 2023, were reviewed and discussed. 4. Approval to release the members of the Board of Directors from their liabilities for the fiscal year ending on December 31, 2023, AD. 5. Approval of the appointment of Maham Professional Consulting Company as the company’s auditor from among the candidates based on the recommendation of the Audit Committee; This is to examine, review and audit the financial statements for the half, first and annual of the fiscal year 2024 AD for a fee amounting to (195,000) one hundred and ninety-five thousand Saudi riyals. 6. Approval of authorizing the Board of Directors to distribute interim dividends to shareholders on a semi- or quarterly basis for the fiscal year ending on 12-31-2024 AD. 7. Approval to delegate to the Board of Directors the authority of the Ordinary General Assembly with the license contained in Paragraph (1) of Article Twenty-Seven of the Companies Law, for a period of one year from the date of approval by the General Assembly or until the end of the session of the delegated Board of Directors, whichever is earlier, in accordance with the conditions contained in the executive regulations of the Law. Private companies of listed joint stock companies. 8. Approval of the business and contracts concluded between the company and the Managing Director and CEO (Dr. Sami Abdullah Al-Saeed), in which he has a direct interest, which are (commissions and bonuses and last for a year) and the value of the transactions during the year 2023 is an amount of (2,350,183) riyals (2,350,183 riyals). Debit transactions) and the value of the amount paid during the year 2023 is (2,260,751) riyals (credit transactions), and the final balance for the year 2023 is (142,644.64) riyals. These transactions are carried out in the normal course of business and in accordance with the prevailing commercial conditions and without any preferential terms.